Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordi Tor

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Scandinavian Journal of Infectious Diseases|April 4, 2013
Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countriesJosep M Llibre, Boris Revollo, Samuel Vanegas, et al.
Antiviral Therapy|January 18, 2005
Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or bothAngel Luis Ballesteros, Oscar Miró, Sònia López, et al.
Antiviral Therapy|November 30, 2005
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapyDaniel Fuster, Jaime A Huertas, Guadalupe Gómez, et al.
BMC Geriatrics|May 11, 2018
Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patientsCristina Pacho, Mar Domingo, Raquel Núñez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 28, 2009
Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virusCristina Tural, Jordi Tor, Arantza Sanvisens, et al.
AIDS Research and Human Retroviruses|January 15, 2005
Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapyDaniel Fuster, Ramon Planas, Robert Muga, et al.
Antiviral Therapy|July 22, 2006
Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological responseDaniel Fuster, Ramon Planas, Juan Gonzalez, et al.
Antiviral Therapy|February 7, 2009
Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patientsCristina Tural, Josep Antón Galeras, Ramon Planas, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Scandinavian Journal of Infectious Diseases|April 4, 2013
Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countriesJosep M Llibre, Boris Revollo, Samuel Vanegas, et al.
Antiviral Therapy|January 18, 2005
Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or bothAngel Luis Ballesteros, Oscar Miró, Sònia López, et al.
Antiviral Therapy|November 30, 2005
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapyDaniel Fuster, Jaime A Huertas, Guadalupe Gómez, et al.
BMC Geriatrics|May 11, 2018
Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patientsCristina Pacho, Mar Domingo, Raquel Núñez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 28, 2009
Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virusCristina Tural, Jordi Tor, Arantza Sanvisens, et al.
AIDS Research and Human Retroviruses|January 15, 2005
Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapyDaniel Fuster, Ramon Planas, Robert Muga, et al.
Antiviral Therapy|July 22, 2006
Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological responseDaniel Fuster, Ramon Planas, Juan Gonzalez, et al.
Antiviral Therapy|February 7, 2009
Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patientsCristina Tural, Josep Antón Galeras, Ramon Planas, et al.
Pageof 5